https://doi.org/10.7490/f1000research.1115943.1
Slides
NOT PEER REVIEWED
Download
metrics
VIEWS
87
 
downloads
9
CITE
How to cite these slides:
Farrugia A. Manufacture of immunoglobulin therapies – relationship to thrombogenicity [version 1; not peer reviewed]. F1000Research 2018, 7:1265 (slides) (https://doi.org/10.7490/f1000research.1115943.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.

Manufacture of immunoglobulin therapies – relationship to thrombogenicity

Author Affiliations
  • Metrics
  • 87 Views
  • 9 Downloads
Browse by related subjects
Published 13 Aug 2018

Manufacture of immunoglobulin therapies – relationship to thrombogenicity

[version 1; not peer reviewed]

Author Affiliations
1 University of Western Australia, Australia
Presented at
Risk Mitigation Strategies to Address Procoagulant Activity in Immune Globulin Products 2011
Abstract
Competing Interests

Consultancy for pharmaceutical industry

Keywords
Immunoglobulin, adverse effects, safety
Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.